Home › Funds › UBS Group AG › MXCT
UBS Group AG position in MXCT
MAXCYTE INC · Health Care
Latest position (Q2 2026)284.27K sh
Reported value held$349.65K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 9.23K | $113.00K | New |
| Q4 2021 | 43.72K | $445.00K | Add |
| Q1 2022 | 2.82K | $20.00K | Reduce |
| Q2 2022 | 19.30K | $91.00K | Add |
| Q3 2022 | 10.94K | $71.00K | Reduce |
| Q4 2022 | 43.71K | $238.65K | Add |
| Q1 2023 | 52.05K | $257.67K | Add |
| Q2 2023 | 70.92K | $325.51K | Add |
| Q3 2023 | 64.93K | $202.58K | Reduce |
| Q4 2023 | 95.57K | $449.20K | Add |
| Q1 2024 | 96.43K | $404.05K | Add |
| Q2 2024 | 49.60K | $194.44K | Reduce |
| Q3 2024 | 68.05K | $264.72K | Add |
| Q4 2024 | 110.65K | $460.29K | Add |
| Q1 2025 | 203.29K | $554.97K | Add |
| Q2 2025 | 165.72K | $361.26K | Reduce |
| Q3 2025 | 474.49K | $749.69K | Add |
| Q4 2025 | 124.59K | $193.12K | Reduce |
| Q1 2026 | 271.05K | $190.55K | Add |
| Q2 2026 | 284.27K | $349.65K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MXCT
- Vanguard Group 5.54M sh · $8.59M · Q4 2025
- Morgan Stanley 3.69M sh · $4.54M · Q2 2026
- BlackRock Inc 3.06M sh · $3.76M · Q2 2026
- Renaissance Technologies 1.91M sh · $2.35M · Q2 2026
- AQR Capital Management 1.88M sh · $2.32M · Q2 2026
- Two Sigma Investments 1.46M sh · $1.80M · Q2 2026
- Geode Capital Management 1.33M sh · $1.63M · Q2 2026
- Goldman Sachs Group 1.24M sh · $1.53M · Q2 2026
- Millennium Management 1.20M sh · $1.48M · Q2 2026
- Marshall Wace 1.01M sh · $1.25M · Q2 2026
- Point72 Asset Management 299.85K sh · $368.82K · Q2 2026